MIM
HBIO icon

Meros Investment Management’s Harvard Bioscience HBIO Stock Holding History

Meros Investment Management’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Buy
182,992
+64,470
+54% +$386K 0.36% 48
2026
Q1 		$577K Sell
118,522
-3,241
-3% -$18.1K 0.25% 50
2025
Q4 		$814K Buy
121,763
+29,937
+33% +$178K 0.32% 44
2025
Q3 		$403K Sell
91,826
-169
-0.2% -$802 0.17% 42
2025
Q2 		$408K Buy
91,995
+12,527
+16% +$52.3K 0.19% 40
2025
Q1 		$450K Sell
79,468
-1,903
-2% -$24.4K 0.26% 38
2024
Q4 		$1.72M Sell
81,371
-1,988
-2% -$45.7K 0.77% 36
2024
Q3 		$2.24M Sell
83,359
-162
-0.2% -$4.77K 1.01% 36
2024
Q2 		$2.38M Buy
83,521
+1,342
+2% +$47.1K 1.13% 34
2024
Q1 		$3.48M Buy
82,179
+204
+0.2% +$9.17K 1.56% 29
2023
Q4 		$4.39M Buy
81,975
+1,263
+2% +$57K 2.08% 22
2023
Q3 		$3.47M Sell
80,712
-589
-0.7% -$27.2K 1.89% 25
2023
Q2 		$4.46M Sell
81,301
-31,120
-28% -$1.71M 2.21% 24
2023
Q1 		$4.72M Sell
112,421
-1,264
-1% -$37.5K 2.69% 18
2022
Q4 		$3.15M Buy
113,685
+40,042
+54% +$987K 1.86% 25
2022
Q3 		$1.89M Buy
73,643
+11,445
+18% +$379K 1.94% 26
2022
Q2 		$2.24M Buy
62,198
+9,639
+18% +$435K 2.08% 27
2022
Q1 		$3.26M Buy
52,559
+9,314
+22% +$551K 2.58% 18
2021
Q4 		$3.05M Buy
+43,245
New +$3.07M 2.23% 22

Other funds holding HBIO

WCM
Weber Capital Management San Francisco, California $118M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
CCM
Corsair Capital Management New York $800M AUM 94.38% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return

Meros Investment Management's HBIO Position: Q2 2026 in Review

Meros Investment Management increased its Harvard Bioscience (HBIO) stake by 54% in Q2 2026, buying an estimated $386K and bringing the position to 182,992 shares worth $1.13M. The position accounts for 0.36% of the portfolio, ranked #48.

Meros Investment Management first reported a position in HBIO in Q4 2021 and has held it in 19 quarters since. The position peaked at $4.72M in Q1 2023. 37 funds tracked by Wall St. Rank hold HBIO as of Q2 2026.

  • Meros Investment Management held 182,992 shares of Harvard Bioscience worth $1.13M as of Q2 2026.
  • Meros Investment Management bought 64,470 Harvard Bioscience shares in Q2 2026, an estimated $386K.
  • Harvard Bioscience made up 0.36% of Meros Investment Management's portfolio in Q2 2026, its #48 holding.
  • Meros Investment Management first reported a position in Harvard Bioscience in Q4 2021 and has held it in 19 quarters since.
  • Meros Investment Management's Harvard Bioscience position peaked at $4.72M in Q1 2023.
  • 37 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2026.

Based on Meros Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.